Status
Conditions
Study type
Funder types
Identifiers
About
Researchers have previously demonstrated loss of heterozygosity in a region on chromosome 18q, associated with osteogenic sarcomas in bone affected by Paget's disease. The loci used in this study are specifically described by those authors as showing loss of heterozygosity in 6 of 7 affected families.
Full description
As above, no additional information
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
8 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal